Avenue Therapeutics, Inc. Gains 32.04%
Wed, Jun 29, 2022 at 08:16 PM
Avenue Therapeutics, Inc. (ATXI:NASDAQ) shot up at $0.32, a gain of 32%. On Wed, Jun 29, 2022, ATXI:NASDAQ touched a New 2-Week High of $0.32. From Wed, Jun 15, 2022, the stock recorded 55.56% Up Days and 50.00% Green Days
The stock spiked on Tue, Mar 01, 2022 at $1.25 with a volume of 208M+.
About Avenue Therapeutics, Inc. (ATXI:NASDAQ)
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of an intravenous, or IV, formulation of tramadol HCl, or IV Tramadol, for the management of moderate to moderately severe postoperative pain.
Top 10 Gainers:
- Allena Pharmaceuticals, Inc. (ALNA:NASDAQ), 114.29%
- Brickell Biotech, Inc. (BBI:NASDAQ), 47.64%
- Decibel Therapeutics Inc. (DBTX:NASDAQ), 44.15%
- Agrico Acquisition Corp. (RICO:NASDAQ), 43.66%
- Aeterna Zentaris Inc. (AEZS:NASDAQ), 39.98%
- Aditxt Inc. (ADTX:NASDAQ), 39.76%
- PARTS iD Inc. Class A (ID:NYSEMKT), 38.24%
- Avenue Therapeutics, Inc. (ATXI:NASDAQ), 32.04%
- Grove Collaborative Holdings Inc. Class A (GROV:NYSE), 29.45%
- 9F Inc. (JFU:NASDAQ), 28.01%